Global Genomics Biomarkers Market to grow at a CAGR of 17.59% during the period 2017 - 2021; Finds New Report

Report forecast the global genomics biomarkers market to grow at a CAGR of 17.59% during the period 2017-2021.

A measurable DNA and/or RNA characteristic is an indicator of normal biologic processes, pathogenic processes, and/or response to a therapeutic or other interventions. A genomic biomarker can be used for measuring the expression, function, and regulation of a gene. These biomarkers have characteristics of one or more deoxyribonucleic acid (DNA) and/or ribonucleic acid (RNA).

The report covers the present scenario and the growth prospects of the global genomics biomarkers market for 2017-2021. To calculate the market size, the report considers the revenue generated from the sales of genomic biomarkers.

The market is divided into the following segments based on geography:

• Americas
• APAC
• EMEA

According to the report, one of the major drivers for this market is genomics biomarker-based personalized medicine. The use of high-throughput technologies provides a better understanding of the pathology of many diseases at the molecular level. This increased the development of new molecular-targeted treatments and enabled the discovery of molecular-based biomarkers like genomics biomarkers that are used in clinical studies.

Further, the report states that one of the major factors hindering the growth of this market is delay in time from lab to market. Since the rise of the supposed omics innovation, thousands of putative biomarkers have been distinguished and published, which have drastically expanded the options for growing more viable therapeutics. These opportunities have significant advantages for patients and for the financial matters of healthcare services. There are a number of challenges for bringing the biomarkers from the clinical research lab to the market, which are time consuming.

Global Genomics Biomarkers Market 2017-2021, has been prepared based on an in-depth market analysis with inputs from industry experts. The report covers the market landscape and its growth prospects over the coming years. The report also includes a discussion of the key vendors operating in this market.

key players in the global genomics biomarkers market: Roche Diagnostics, Myriad Genetics, QIAGEN, Thermo Fisher Scientific, and Bio-Rad Laboratories.

Other Prominent Vendors in the market are: 23andMe, Aepodia, Almac, AROS Applied Biotechnology, DNAVision, Epigenomics, Epistem, Eurofins Scientific, Foundation Medicine, Genomic Health, Liquid Genomics, New England Biolabs, OriGene, and US Biomarkers.

Market driver

• Genomics biomarker-based personalized medicine
• For a full, detailed list, view our report

Market challenge

• Delay in time from lab to market
• For a full, detailed list, view our report

Market trend

• Expansion of new business models
• For a full, detailed list, view our report

Key questions answered in this report

• What will the market size be in 2021 and what will the growth rate be?
• What are the key market trends?
• What is driving this market?
• What are the challenges to market growth?
• Who are the key vendors in this market space?
• What are the market opportunities and threats faced by the key vendors?
• What are the strengths and weaknesses of the key vendors?

Spanning over 83 pages and 48 Exhibits “Global Genomics Biomarkers Market 2017 - 2021” report covers Executive summary, Scope of the report, Market research methodology, Introduction, Market landscape, Market segmentation by indication, Market segmentation by end-user, Geographical segmentation, Market drivers, Impact of drivers, Market challenges, Impact of drivers and challenges, Market trends, Vendor landscape, Key vendor analysis, Appendix.

For more information Visit at: http://mrr.cm/3tR

Find all Medical Devices Reports at: http://www.marketresearchreports.com/medical-devices